Artificial valved blood vessels
By designing a three-layer structure consisting of a tissue valve, an artificial blood vessel containing a valve sinus, and an artificial valve support ring, the problems of poor durability, difficulty in material acquisition, and difficulty in interventional treatment of existing artificial valved vascular prostheses are solved. This results in a highly efficient and durable vascular substitute suitable for patients with different diseases and weights, applicable to vascular repair from the right ventricle to the pulmonary artery and from the left ventricle to the aorta.
Patent Information
- Application Number
- CN201910299015.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2019-04-15
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2039-04-15
AI Technical Summary
Existing artificial valved vascular prostheses suffer from problems such as calcification of the vessel wall, stenosis, and aneurysmal dilatation. Furthermore, they are difficult to dilate with balloons and reimplant through percutaneous interventional techniques. They are also difficult to obtain materials, difficult to match in size, inconvenient to supply, have poor durability, and have poor long-term treatment effects.
The system employs a three-layer structure consisting of a tissue valve, an artificial blood vessel containing a valve sinus, and an artificial valve support ring. The tissue valve is located inside the valve sinus, while the artificial valve support ring is located outside the valve sinus. The two layers are connected by medical sutures. Using medical polymer materials and elastic metal materials, the system is designed to be tailorable and malleable, increasing vascular strength, reducing immunogenicity, and marking blood flow direction and cutting restriction lines to facilitate operation.
It improves the durability of artificial valved vessels, reduces the immunogenicity of materials, is suitable for patients with different diseases and weights, is easy to implant and percutaneously intervene in, significantly improves long-term treatment results, reduces the risk of calcification and decay, and is suitable for vascular replacement from the right ventricle to the pulmonary artery and from the left ventricle to the aorta.
Smart Images

Figure CN109907860B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedical engineering and relates to an artificial prosthesis, more specifically an artificial prosthesis which is implanted through cardiac surgery and is used to reconstruct or repair the blood vessels from the right ventricle to the pulmonary artery or from the left ventricle to the aorta. Background Art
[0002] Currently, there are a variety of technologies used in artificial valved vascular prostheses, but these technologies all have certain problems.
[0003] In the 1980s, allogeneic valved blood vessels were used to reconstruct the right ventricular outflow tract with valves. Subsequently, problems such as calcification of the vascular wall and valves, and hemangioma-like dilatation were discovered. At the same time, allogeneic valved blood vessels also have problems such as difficulty in obtaining materials, difficulty in matching sizes, and inconvenient supply. Later, artificial valved blood vessels that combined artificial biological valves or artificial mechanical valves with artificial braided blood vessels appeared. Because their structures contain complete artificial biological valves or artificial mechanical valves, the artificial valves occupy a large space in the artificial blood vessels, resulting in greater blood flow resistance, especially for blood vessels with smaller diameters. This problem is more prominent. In the past decade, bovine jugular vein valved blood vessels have been used as heart vascular substitutes, and commercial products have appeared. However, they have problems such as severe vascular wall calcification, distal anastomotic fibrosis and stenosis, and tumor-like dilatation.
[0004] Currently, percutaneous interventional treatment technology is developing rapidly and is accepted by patients and doctors. After the occurrence of stenosis, the above-mentioned commonly used artificial valved vascular prostheses will encounter great difficulties if percutaneous interventional treatment technology is used for balloon dilatation, intravascular stents or re-implantation of interventional valves. For example, balloon dilatation of calcified and stenotic parts of allogeneic valved vessels and bovine jugular vein valved vessels can easily cause rupture of the vessel wall; after the artificial valve of an artificial blood vessel fails, it is difficult to re-implant the interventional valve through interventional means due to its structural limitations.
[0005] Therefore, there is a need for an artificial valved blood vessel with more complete functions, better durability, easier availability, more complete specifications, easier implantation, and the ability to achieve better long-term treatment effects. Summary of the invention
[0006] The purpose of the present invention is to solve the problems existing in the existing known technology and to provide an artificial valved blood vessel with complete functions, good durability, easy availability, complete specifications, convenient supply, and easy implantation, which can achieve more satisfactory long-term treatment effects after implantation.
[0007] In order to achieve the above objectives and solve the above key technical problems, the present invention adopts the following technical solutions:
[0008] An artificial valved blood vessel comprises a tissue valve, an artificial blood vessel containing a valve sinus and an artificial valve support ring; the tissue valve is located in the valve sinus of the artificial blood vessel containing the valve sinus, the artificial valve support ring is located outside the valve sinus of the artificial blood vessel containing the valve sinus, and the valve ring of the tissue valve overlaps with the artificial valve support ring; the tissue valve, the artificial blood vessel containing the valve sinus and the artificial valve support ring are sutured and connected by medical sutures.
[0009] The tissue valve is a complete natural three-leaflet valve, or a three-leaflet valve made by splicing three tissue leaflets or bovine pericardium sheets. The artificial blood vessel containing the valve sinus includes a first conduit, a valve sinus and a second conduit. The artificial valve support ring is an elastic sheet ring similar in shape to the valve ring of the natural three-leaflet valve, and has suture holes thereon.
[0010] The tissue valve is a complete natural three-leaflet valve, or a three-leaflet valve made by splicing three tissue leaflets or bovine pericardium pieces.
[0011] The tissue valve is a three-leaf structure valve with intact structure, morphology and function from a processed bovine jugular vein, which is cut at a certain distance from the upper and lower edges of the valve ring to the blood vessel wall. Preferably, the distance between the cutting position and the upper and lower edges of the tissue valve ring is 3-5 mm. The valve ring of the cut tissue valve is still annular, and the valve leaflets and valve ring still retain the complete valve structure and function.
[0012] The tissue valve can also be a valve made by cutting the tissue leaflets with intact structure and morphology from the processed natural blood vessels with valves at a certain distance from the upper and lower edges of the valve ring of the blood vessel wall, and selecting three tissue leaflets of the same size, thickness and shape to splice together. Preferably, the distance between the cutting position and the upper and lower edges of the valve ring of the tissue leaflets is 3-5mm. The tissue leaflets are the leaflets of the tissue valve, and the valve ring of the three tissue leaflets forms a ring shape that is consistent with the valve ring shape of the natural three-leaflet structure valve, which is the valve ring of the tissue valve.
[0013] The tissue valve leaflets may be valve leaflets in bovine jugular vein, valve leaflets of a three-leaflet structure valve, a two-leaflet structure valve, or a single-leaflet structure valve, or may be non-coronary sinus valve leaflets in porcine aorta.
[0014] The tissue valve can also be a valve made by cutting the processed bovine pericardium into roughly fan-shaped pieces, and selecting three bovine pericardium pieces of the same size and thickness to splice. Preferably, the width of the cut bovine pericardium piece is 16-38 mm, and the height is 7-28 mm. The main part of the fan-shaped surface of the bovine pericardium piece is the leaflet of the tissue valve, and the bottom edges of the three bovine pericardium pieces form a ring shape that is consistent with the shape of the valve ring of the natural three-leaflet structure valve, which is the valve ring of the tissue valve.
[0015] The tissue valve has the structure and function of a three-leaflet valve. Preferably, the inner diameter of the valve ring of the tissue valve is 8-26 mm, and the height of the tissue valve is 4-18 mm.
[0016] The treatment includes but is not limited to physical and chemical treatment by soaking in 0.256%-0.625% glutaraldehyde solution for 12-48 hours under the conditions of 25-45 mmHg pressure and 4-37°C temperature.
[0017] The artificial blood vessel containing the valve sinus comprises a first conduit, a valve sinus and a second conduit, wherein the valve sinus is located between the distal end of the first conduit and the proximal end of the second conduit. The inner diameters of the first conduit and the second conduit of the same artificial blood vessel containing the valve sinus are the same, and are the same as the inner diameter of the valve ring of the tissue valve located in the valve sinus. The inner diameter of the valve sinus of the same artificial blood vessel containing the valve sinus is larger than the inner diameters of the first conduit and the second conduit, and is the same as the outer diameter of the valve ring of the tissue valve located in the valve sinus. The valve sinus is generally convex relative to the first conduit and the second conduit. The first conduit, the valve sinus and the second conduit constitute a continuous and complete artificial blood vessel containing the valve sinus. Preferably, the inner diameters of the first conduit and the second conduit are 8-26 mm, the inner diameters of the valve sinus are 2-4 mm larger than the inner diameters of the first conduit and the second conduit of the same artificial blood vessel containing the valve sinus, and the height of the valve sinus is 6-28 mm.
[0018] The artificial blood vessel containing the valve sinus is made of medical polymer materials. Preferably, the wall thickness of the artificial blood vessel is 0.2-0.8 mm. The first pipe and the second pipe can be bent, cut, and sutured, and can maintain a tubular shape and corresponding elasticity during operation and use.
[0019] The artificial valve support ring is an elastic sheet ring, and its shape is similar to the shape of the valve ring of a natural three-leaf structure valve, which is roughly a ring surrounded by three parabolas opening upward. The inner diameter of the artificial valve support ring is the same as the outer diameter of the valve sinus of the artificial blood vessel containing the valve sinus. There are two rows of suture holes on the artificial valve support ring, which are respectively located near the upper and lower edges of the artificial valve support ring; the artificial valve support ring can also have a row of suture holes located in the middle of the ring wall of the artificial valve support ring.
[0020] The artificial valve support ring is made of medical polymer material or elastic metal material. Preferably, the height from the bottom to the top of the artificial valve support ring is 5-26 mm, the inner diameter of the support ring is 10.4-31.6 mm, the thickness of the support ring wall is 0.1-1.1 mm, and the width of the support ring is 5-24 mm.
[0021] In the artificial valved blood vessel, the tissue valve is located in the valve sinus of the artificial blood vessel containing the valve sinus, the blood inlet end of the tissue valve is close to the distal end of the first conduit of the artificial blood vessel containing the valve sinus, and the bleeding end of the tissue valve is close to the proximal end of the second conduit of the artificial blood vessel containing the valve sinus; the artificial valve support ring is located outside the valve sinus of the artificial blood vessel containing the valve sinus, overlapping with the valve ring position of the tissue valve, the bottom of the artificial valve support ring is close to the distal end of the first conduit of the artificial blood vessel containing the valve sinus, and the top of the artificial valve support ring is close to the proximal end of the second conduit of the artificial blood vessel containing the valve sinus. The medical suture thread runs along the direction of the valve ring of the tissue valve, passes through the upper and lower edge blood vessel walls of the valve ring of the tissue valve, the valve sinus of the artificial blood vessel containing the valve sinus, and the suture holes on the artificial valve support ring, and sutures the above three-layer structure together at the same time.
[0022] The artificial valve-bearing blood vessel can also overlap the position of the valve ring of the tissue valve leaflet; the medical suture thread runs along the direction of the valve ring of the tissue valve leaflet, passes through the upper and lower edges of the blood vessel wall of the valve ring of the tissue valve leaflet, the valve sinus of the artificial blood vessel containing the valve sinus, and the suture hole on the artificial valve support ring, and the above three-layer structure is sutured together at the same time. The blood inlet end of the tissue valve is the end where the valve ring of the tissue valve leaflet is located, and the bleeding end of the tissue valve is the end where the free edge of the tissue valve leaflet is located.
[0023] The artificial valve-bearing blood vessel, its artificial valve support ring can also overlap with the bottom edge of the bovine pericardium sheet; the medical suture line runs along the bottom edge of the bovine pericardium sheet, at a certain distance from the bottom edge of the bovine pericardium sheet, preferably, the distance is 1-3mm, through the bovine pericardium sheet, the valve sinus of the artificial blood vessel containing the valve sinus, and the suture hole on the artificial valve support ring, and the above three-layer structure is sutured together at the same time. The blood inlet end of the tissue valve is the end where the bottom edge of the bovine pericardium sheet is located, and the bleeding end of the tissue valve is the end where the top edge of the bovine pericardium sheet is located.
[0024] The artificial valved blood vessel, the artificial blood vessel containing the valve sinus, has two cutting limit lines, which are used to remind the operator of the maximum position that the artificial valved blood vessel can be cut. The two cutting limit lines are respectively located at a certain distance from the valve sinus to the distal end of the first pipe and the proximal end of the second pipe. Preferably, the distance is 6 mm.
[0025] The artificial valved blood vessel, including the valve sinus, is provided with a blood flow direction mark, which is used to remind the operator of the opening direction of the tissue valve of the artificial valved blood vessel, that is, the direction when sutured to human tissue. The blood flow direction mark is located on the valve sinus, the arrow direction of the mark is the bleeding end of the tissue valve, and the tail direction of the arrow is the blood inlet end of the tissue valve.
[0026] The “proximal end”, “lower end” and “bottom end” mentioned in this article all refer to the end of the structure close to the human heart, and the “distal end”, “upper end” and “top end” mentioned in this article all refer to the end of the structure farthest from the human heart.
[0027] The method for preparing the artificial valved blood vessel comprises the following steps:
[0028] (1) The three-leaflet valve in the processed bovine jugular vein is cut off along the upper and lower edges of the valve ring at a certain distance from the blood vessel wall, and the valve ring of the cut tissue valve is still annular, and the valve leaflets and the valve ring still retain the complete valve structure and function;
[0029] (2) placing the tissue valve in the valve sinus of the artificial blood vessel containing the valve sinus, and placing the artificial valve support ring outside the valve sinus of the artificial blood vessel containing the valve sinus, so that the artificial valve support ring and the valve ring of the tissue valve overlap; using medical sutures along the direction of the valve ring of the tissue valve, so that the medical sutures pass through the upper and lower edge blood vessel walls of the valve ring of the tissue valve, the valve sinus of the artificial blood vessel containing the valve sinus, and the suture holes on the artificial valve support ring, and sew the above three-layer structure together at the same time.
[0030] The method for preparing the artificial valved blood vessel may also include the following steps:
[0031] (1) cutting the tissue leaflets of the processed natural blood vessel with valve at a certain distance along the upper and lower edges of the valve ring and the blood vessel wall;
[0032] (2) selecting three tissue leaflets of the same size, thickness and shape, placing one of the tissue leaflets in the valve sinus of the artificial blood vessel containing the valve sinus, placing the artificial valve support ring outside the valve sinus of the artificial blood vessel containing the valve sinus, so that the artificial valve support ring and the valve ring of the tissue leaflet overlap; using a medical suture thread along the direction of the valve ring of the tissue leaflet, so that the medical suture thread passes through the upper and lower edges of the valve ring of the tissue leaflet, the valve sinus of the artificial blood vessel containing the valve sinus, and the suture holes on the artificial valve support ring, and sutures the above three-layer structure together at the same time;
[0033] (3) Using the same method, the second and third tissue valve leaflets are sequentially sutured to the valve sinus of the artificial blood vessel containing the valve sinus and the artificial valve support ring.
[0034] The method for preparing the artificial valved blood vessel may further include the following steps:
[0035] (1) cutting the processed bovine pericardium slices into roughly fan-shaped slices;
[0036] (2) selecting three bovine pericardium sheets of the same size and thickness, placing one of the bovine pericardium sheets in the valve sinus of the artificial blood vessel containing the valve sinus, and placing the artificial valve support ring outside the valve sinus of the artificial blood vessel containing the valve sinus, so that the artificial valve support ring overlaps with the bottom edge of the bovine pericardium sheet; using a medical suture thread at a certain distance from the bottom edge of the bovine pericardium sheet and along the direction of the bottom edge of the bovine pericardium sheet, passing the medical suture thread through the suture holes on the bovine pericardium sheet, the valve sinus of the artificial blood vessel containing the valve sinus, and the artificial valve support ring, so as to sew the above three-layer structure together at the same time;
[0037] (3) Using the same method, sew the second and third bovine pericardium pieces to the valve sinus of the artificial blood vessel containing the valve sinus and the artificial valve support ring.
[0038] The artificial valved blood vessel of the present invention is implanted through cardiac surgery and is used to reconstruct or repair the blood vessel from the right ventricle to the pulmonary artery, or the blood vessel from the left ventricle to the aorta.
[0039] The present invention has the following beneficial technical effects:
[0040] 1. The artificial blood vessel replaces the blood vessel part of the natural blood vessel with valve, which increases the strength of the blood vessel, so that the artificial valved blood vessel of the present invention is not only suitable for the pressure environment of the human right ventricle to pulmonary artery system, but also suitable for the pressure environment of the human left ventricle to aorta system. Therefore, it can be used as a substitute for the blood vessel from the human right ventricle to the pulmonary artery, and can also be used as a substitute for the blood vessel from the human left ventricle to the aorta.
[0041] 2. It not only utilizes the structure and function of tissue valves, but also removes as much natural biological tissue as possible and replaces it with medical polymer materials, thereby reducing the immunogenicity of the materials, avoiding the drawbacks of biological tissues being easily calcified and decayed, significantly improving the durability of artificial valved blood vessels, inhibiting the occurrence of calcification, and achieving satisfactory long-term treatment effects.
[0042] 3. The design of the valve sinus in the artificial blood vessel can maintain the diameter of the artificial valved blood vessel and minimize the transvalvular pressure difference.
[0043] 4. The artificial valve support ring can effectively maintain the shape of the tissue valve, prevent the tissue valve from deformation, and ensure the valve function.
[0044] 5. The tube part of the artificial blood vessel has good cuttability and plasticity, and is easy to suture with human tissue to match its location.
[0045] 6. Artificial blood vessels have good strength and elasticity, which facilitates the use of percutaneous interventional treatment techniques for balloon dilatation, intravascular stents and interventional valve implantation.
[0046] 7. The three-layer structure of tissue valve, artificial blood vessel containing valve sinus, and artificial valve support ring are sewn together at the same time. This structure maintains the movement and force mode of tissue valve, making the valve more durable.
[0047] 8. The cutting limit line clearly marks the area where cutting is prohibited, which is used to remind the operator the maximum position where the artificial valved blood vessel can be cut, and the valve structure will not be damaged due to cutting.
[0048] 9. The blood flow direction mark clearly indicates the blood flow direction when the valve is in working condition, and is used to remind the operator of the direction of the tissue valve opening of the artificial valved blood vessel, so that the operator can quickly and accurately identify the suturing direction of the artificial valved blood vessel.
[0049] 10. The tissue valve can be a complete natural three-leaflet valve structure, or a three-leaflet valve structure valve made by splicing three tissue leaflets or bovine pericardium pieces. The tissue leaflets are selected from the leaflets in the bovine jugular vein or the non-coronary sinus leaflets in the porcine aorta. The material is easy to obtain and can be fully utilized, significantly improving the selection rate. Moreover, the tissue valve made by splicing tissue leaflets or bovine pericardium pieces can expand the specification range of the artificial valved blood vessels produced, and is suitable for patients with different diseases and different weights.
[0050] 11. Artificial valved blood vessels are much easier to store and transport than allogeneic materials and have great advantages in supply. BRIEF DESCRIPTION OF THE DRAWINGS
[0051] Figure 1 It is a structural schematic diagram of the present invention.
[0052] Figure 2 It is a schematic diagram of the top structure of the present invention.
[0053] Figure 3 It is a schematic diagram of the structure of the tissue valve in the first embodiment of the present invention.
[0054] Figure 4 It is a schematic diagram of the structure of the tissue leaflet in the second embodiment of the present invention.
[0055] Figure 5 It is a schematic diagram of the structure of the bovine pericardium slice in Example 3 of the present invention.
[0056] Figure 6 It is a schematic diagram of the structure of an artificial blood vessel containing a valve sinus in the first embodiment of the present invention.
[0057] Figure 7 It is a schematic diagram of the structure of the artificial valve support ring in the first embodiment of the present invention.
[0058] Figure 8 It is a schematic longitudinal section diagram of the first embodiment of the present invention.
[0059] Fig. 9 It is a schematic diagram of the appearance of the first embodiment of the present invention.
[0060] Fig.10 It is a schematic longitudinal section diagram of the second embodiment of the present invention.
[0061] Fig.11 It is a schematic diagram of the structure of the artificial valve support ring in the third embodiment of the present invention.
[0062] Fig.12 It is a schematic longitudinal section diagram of the third embodiment of the present invention.
[0063] Fig.13 It is a schematic diagram of the appearance of the third embodiment of the present invention. DETAILED DESCRIPTION
[0064] The present invention will be further explained below with reference to specific embodiments in conjunction with the accompanying drawings, and the embodiments do not constitute a limitation of the present invention.
[0065] Reference Figure 1 and Figure 2 The artificial valved blood vessel is composed of a tissue valve 1, an artificial blood vessel 2 containing a valve sinus, and an artificial valve support ring 3. The tissue valve 1 is located in the valve sinus of the artificial blood vessel 2 containing a valve sinus, and the artificial valve support ring 3 is located outside the valve sinus of the artificial blood vessel 2 containing a valve sinus. The valve ring of the tissue valve 1 overlaps with the artificial valve support ring 3. The tissue valve 1, the artificial blood vessel 2 containing a valve sinus, and the artificial valve support ring 3 are sutured and connected by medical sutures.
[0066] Embodiment 1
[0067] In the first embodiment of the present invention, the tissue valve 1 is a complete natural three-leaflet valve.
[0068] like Figure 3 As shown, the tissue valve 1 is a three-leaf structure valve 1 with intact structure, morphology and function in a processed bovine jugular vein, which is cut along a certain distance from the upper and lower edges of the valve ring 112 to the blood vessel wall 113. Preferably, the distance between the cutting position and the upper and lower edges of the valve ring 112 is 3-5 mm. The valve ring 112 of the cut tissue valve 1 is still annular, and the leaflets 111 and the valve ring 112 still retain the complete valve structure and function.
[0069] like Figure 6As shown, the artificial blood vessel 2 containing valve sinuses includes a first conduit 201, a valve sinus 203, and a second conduit 202. The valve sinus 203 is located between the distal end of the first conduit 201 and the proximal end of the second conduit 202. The inner diameters of the first conduit 201 and the second conduit 202 are the same, and are the same as the inner diameter of the valve ring 112 of the tissue valve 1 located in the valve sinus 203. The inner diameter of the valve sinus 203 is larger than the inner diameters of the first conduit 201 and the second conduit 202, and is the same as the outer diameter of the valve ring 112 of the tissue valve 1 located in the valve sinus 203. The valve sinus 203 is generally convex relative to the first conduit 201 and the second conduit 202. The first conduit 201, the valve sinus 203, and the second conduit 202 constitute a continuous and complete artificial blood vessel 2 containing valve sinuses.
[0070] The artificial blood vessel 2 with valve sinus has two cutting limit lines 204, which are used to remind the operator of the maximum position that the artificial valved blood vessel can be cut. The two cutting limit lines 204 are respectively located at a certain distance from the valve sinus 203 at the distal end of the first pipe 201 and the proximal end of the second pipe 202.
[0071] The artificial blood vessel 2 with valve sinus has a blood flow direction mark 205, which is used to remind the operator of the opening direction of the tissue valve 1 of the artificial valved blood vessel, that is, the direction when sutured to human tissue. The blood flow direction mark 205 is located on the valve sinus 203, and the direction of the marked arrow is the bleeding end of the tissue valve 1, and the direction of the tail of the arrow is the blood inlet end of the tissue valve 1.
[0072] The artificial blood vessel 2 containing the valve sinus is made of medical polymer materials. The first pipe 201 and the second pipe 202 can be bent, cut, and sutured, and can maintain a tubular shape and corresponding elasticity during operation and use.
[0073] like Figure 7 As shown, the artificial valve support ring 3 is an elastic sheet ring, and its shape is similar to the shape of the valve ring of a natural three-leaf structure valve, which is roughly a ring surrounded by three upwardly opening parabolas. The inner diameter of the artificial valve support ring 3 is the same as the outer diameter of the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus. There are two rows of suture holes 301 on the artificial valve support ring 3, which are respectively located near the upper and lower edges of the artificial valve support ring 3. The artificial valve support ring 3 is made of elastic metal material.
[0074] See also Figure 1 and Figure 8The tissue valve 1 is located in the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, the blood inlet end of the tissue valve 1 is close to the distal end of the first conduit 201 of the artificial blood vessel 2 containing the valve sinus, and the bleeding end of the tissue valve 1 is close to the proximal end of the second conduit 202 of the artificial blood vessel 2 containing the valve sinus; the artificial valve support ring 3 is located outside the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, overlapping with the valve ring 112 of the tissue valve 1, the bottom of the artificial valve support ring 3 is close to the distal end of the first conduit 201 of the artificial blood vessel 2 containing the valve sinus, and the top of the artificial valve support ring 3 is close to the proximal end of the second conduit 202 of the artificial blood vessel 2 containing the valve sinus. The medical suture thread runs along the direction of the valve ring 112 of the tissue valve 1, passes through the upper and lower edge vascular wall 113 of the valve ring 112 of the tissue valve 1, the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, and the suture hole 301 on the artificial valve support ring 3, and sutures the above three-layer structure together at the same time.
[0075] Fig. 9 It is a schematic diagram of the appearance of the first embodiment. From the outside, the artificial valved blood vessel 2 containing the valve sinus includes a first conduit 201, a second conduit 202, a valve sinus 203, a cutting limit line 204 and a blood flow direction mark 205; the artificial valve support ring 3 is sutured outside the valve sinus 203 of the artificial valve support ring 2 containing the valve sinus, the bottom of the artificial valve support ring 3 is close to the distal end of the first conduit 201 of the artificial valve support ring 2 containing the valve sinus, and the top of the artificial valve support ring 3 is close to the proximal end of the second conduit 202 of the artificial valve support ring 2 containing the valve sinus. There are two rows of suture holes 301 on the artificial valve support ring 3, which are respectively located near the upper and lower edges of the artificial valve support ring 3.
[0076] The preparation method of the above-mentioned artificial valved blood vessel is as follows:
[0077] (1) The three-leaflet tissue valve 1 in the processed bovine jugular vein is cut off along the upper and lower edges of the valve ring 112 at a certain distance from the blood vessel wall 113, and the valve ring 112 of the cut tissue valve 1 is still annular, and the leaflets 111 and the valve ring 112 still retain the complete valve structure and function;
[0078] (2) placing the tissue valve 1 in the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, and placing the artificial valve support ring 3 outside the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, so that the artificial valve support ring 3 overlaps with the valve ring 112 of the tissue valve 1; using medical sutures along the direction of the valve ring 112 of the tissue valve 1, the medical sutures are passed through the upper and lower edge vascular walls 113 of the valve ring 112 of the tissue valve 1, the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, and the suture holes 301 on the artificial valve support ring 3, so as to sew the above three-layer structure together at the same time.
[0079] Embodiment 2
[0080] In the second embodiment of the present invention, the tissue valve 1 is a three-leaflet structure valve made by splicing three tissue leaflets.
[0081] like Figure 4 As shown, the tissue leaflets 121 with intact structure and morphology in the processed bovine jugular vein are cut off at a certain distance from the upper and lower edges of the valve ring 122 to the vascular wall 123. Preferably, the distance between the cutting position and the upper and lower edges of the valve ring 122 is 3-5 mm.
[0082] The tissue valve 1 is a valve made of three tissue leaflets 121 of the same size, thickness and shape. The tissue leaflets 121 are the leaflets of the tissue valve 1, and the valve ring 122 of the three tissue leaflets 121 forms a ring shape consistent with the valve ring shape of a natural three-leaflet structure valve, which is the valve ring of the tissue valve 1.
[0083] The structures and materials of the artificial blood vessel 2 containing the valve sinus and the artificial valve support ring 3 described in this embodiment are the same as those in the first embodiment.
[0084] See also Figure 1 and Fig.10 The tissue valve 1 is located in the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, the blood inlet end of the tissue valve 1 is close to the distal end of the first conduit 201 of the artificial blood vessel 2 containing the valve sinus, and the bleeding end of the tissue valve 1 is close to the proximal end of the second conduit 202 of the artificial blood vessel 2 containing the valve sinus; the artificial valve support ring 3 is located outside the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, overlapping with the valve ring 122 of the tissue valve leaf 121, the bottom of the artificial valve support ring 3 is close to the distal end of the first conduit 201 of the artificial blood vessel 2 containing the valve sinus, and the top of the artificial valve support ring 3 is close to the proximal end of the second conduit 202 of the artificial blood vessel 2 containing the valve sinus; the medical suture thread runs along the direction of the valve ring 122 of the tissue valve leaf 121, passes through the upper and lower edges of the valve ring 122 of the tissue valve leaf 121, the vascular wall 123, the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, and the suture hole 301 on the artificial valve support ring 3, and sutures the above three-layer structure together at the same time. The blood inlet end of the tissue valve 1 is the end where the valve ring 122 of the tissue valve leaflet 121 is located, and the bleeding end of the tissue valve 1 is the end where the free edge 124 of the tissue valve leaflet 121 is located.
[0085] The appearance of this embodiment is the same as that of the first embodiment.
[0086] The preparation method of the above-mentioned artificial valved blood vessel is as follows:
[0087] (1) Cutting the tissue leaflets 121 with intact structure and morphology from the processed natural blood vessel with valve along the upper and lower edges of the valve ring 122 at a certain distance from the blood vessel wall 123;
[0088] (2) Select three tissue leaflets 121 of the same size, thickness and shape, place one of the tissue leaflets 121 in the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, place the artificial valve support ring 3 outside the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, so that the artificial valve support ring 3 overlaps with the valve ring 122 of the tissue leaflet 121; use medical sutures along the direction of the valve ring 122 of the tissue leaflet 121 to make the medical sutures pass through the upper and lower edges of the blood vessel wall 123 of the valve ring 122 of the tissue leaflet 121, the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, and the suture holes 301 on the artificial valve support ring 3, and sew the above three-layer structure together at the same time;
[0089] (3) Using the same method, the second and third tissue leaflets 121 are sequentially sutured to the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus and the artificial valve support ring 3.
[0090] Embodiment 3
[0091] In the third embodiment of the present invention, the tissue valve 1 is a three-leaflet valve made by splicing three bovine pericardium pieces.
[0092] like Figure 5 As shown, the bovine pericardium slice 131 is a roughly fan-shaped slice cut from processed bovine pericardium slices, and the bottom edge of the bovine pericardium slice 131 is 132 and the top edge is 133. Preferably, the width of the bovine pericardium slice 131 is 16-38 mm and the height is 7-28 mm.
[0093] The tissue valve 1 is a valve made of three bovine pericardium sheets 131 of uniform size and thickness. The main part of the fan-shaped surface of the bovine pericardium sheet 131 is the leaflet of the tissue valve 1, and the bottom edges 132 of the three bovine pericardium sheets 131 form a ring shape that is consistent with the shape of the valve ring of a natural three-leaflet structure valve, which is the valve ring of the tissue valve 1.
[0094] The structure and material of the artificial blood vessel 2 containing the valve sinus described in this embodiment are the same as those in the first embodiment.
[0095] like Fig.11 As shown, the artificial valve support ring 3 of this embodiment is the same as that of the first embodiment except that it has a row of suture holes 302 located in the middle of the wall of the artificial valve support ring. The artificial valve support ring 3 is made of elastic metal material.
[0096] See also Figure 1 and Fig.12The tissue valve 1 is located in the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, the blood inlet end of the tissue valve 1 is close to the distal end of the first conduit 201 of the artificial blood vessel 2 containing the valve sinus, and the bleeding end of the tissue valve 1 is close to the proximal end of the second conduit 202 of the artificial blood vessel 2 containing the valve sinus; the artificial valve support ring 3 is located outside the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, and overlaps with the bottom edge 132 of the bovine pericardium sheet 131, and the bottom of the artificial valve support ring 3 is close to the first conduit 201 of the artificial blood vessel 2 containing the valve sinus. The distal end of the artificial valve support ring 3 is close to the distal end of the second conduit 201 of the artificial blood vessel 2 containing the valve sinus; the medical suture thread runs along the bottom edge 132 of the bovine pericardium sheet 131, at a certain distance from the bottom edge 132 of the bovine pericardium sheet 131, preferably, the distance is 1-3mm, through the bovine pericardium sheet 131, the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, and the suture hole 302 on the artificial valve support ring 3, and the above three-layer structure is sutured together at the same time. The blood inlet end of the tissue valve 1 is the end where the bottom edge 132 of the bovine pericardium sheet 131 is located, and the bleeding end of the tissue valve 1 is the end where the top edge 133 of the bovine pericardium sheet 131 is located.
[0097] Fig.13 This is a schematic diagram of the appearance of Embodiment 3. From the outside, the artificial valved blood vessel described in this embodiment is the same as that of Embodiment 1, except that there is a row of suture holes 302 on the artificial valve support ring 3, which is located in the middle of the annular wall of the artificial valve support ring.
[0098] The preparation method of the above-mentioned artificial valved blood vessel is as follows:
[0099] (1) cutting the processed bovine pericardium slices into roughly fan-shaped bovine pericardium slices 131;
[0100] (2) Select three bovine pericardium sheets 131 of the same size and thickness, place one of the bovine pericardium sheets 131 in the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, and place the artificial valve support ring 3 outside the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, so that the artificial valve support ring 3 overlaps with the bottom edge 132 of the bovine pericardium sheet 131; use a medical suture thread at a certain distance from the bottom edge 132 of the bovine pericardium sheet 131, along the direction of the bottom edge 132 of the bovine pericardium sheet 131, so that the medical suture thread passes through the bovine pericardium sheet 131, the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus, and the suture hole 302 on the artificial valve support ring 3, and sew the above three-layer structure together at the same time;
[0101] (3) Using the same method, the second and third bovine pericardium sheets 131 are sequentially sutured to the valve sinus 203 of the artificial blood vessel 2 containing the valve sinus and the artificial valve support ring 3.
[0102] The artificial valved blood vessel of the present invention is implanted through cardiac surgery and is used to reconstruct or repair the blood vessel from the right ventricle to the pulmonary artery, or from the left ventricle to the aorta. The method of use is as follows:
[0103] 1. Used as a substitute for the blood vessels from the right ventricle to the pulmonary artery. The typical usage is:
[0104] In the operation for treating pulmonary atresia, the artificial valved blood vessel of the present invention is used to reconstruct the blood vessel from the right ventricle to the pulmonary artery. The proximal end of the first conduit of the present invention is directly anastomosed to the right ventricle incision, and the distal end of the second conduit is anastomosed to the bifurcation of the pulmonary artery.
[0105] In the operation for treating pulmonary artery agenesis syndrome, the artificial valved blood vessel of the present invention is used to completely replace the tumor-like dilated pulmonary artery. The distal end of the second conduit of the present invention is completely sutured, and then an opening is cut out on the left and right sides of the second conduit, so that the left and right pulmonary arteries are respectively anastomosed end to end with the openings cut out of the second conduit. The proximal end of the first conduit is cut to expand like a hood and anastomosed with the right ventricle.
[0106] 2. Used as a substitute for the blood vessels from the left ventricle to the aorta. The typical usage is:
[0107] In the treatment of left ventricular outflow tract obstruction surgery for patients with severe hypoplasia of the ascending aorta, supravalvular stenosis who are not suitable for plasty, or severe calcification of the aortic root, which makes it impossible to undergo general valve replacement surgery, the artificial valved blood vessel of the present invention is used to perform left apex to descending aorta bypass. The left ventricular wall is incised in the apical non-vascular area, and the proximal end of the first conduit of the present invention is anastomosed with the apical incision. Then, an incision is made on the diaphragmatic surface near the apex, and the anastomosed artificial valved blood vessel of the present invention is delivered to the abdominal cavity through the incision, and the distal end of the second conduit of the present invention is anastomosed end-to-side with the abdominal aorta. The tissue valve in the artificial valved blood vessel of the present invention is located in the abdominal cavity below the diaphragm. If another operation is needed in the future, only the abdominal cavity needs to be incised without opening the chest.
[0108] The artificial valved blood vessel involved in the present invention is introduced in detail above. Specific examples are used herein to illustrate the principles and implementation methods of the present invention. The description of the above embodiments is only used to help understand the method of the present invention and its core idea. It should be pointed out that the present invention is not limited to the above exemplary embodiments, and those skilled in the art may make various changes and modifications without departing from the principles, scope or spirit of the present invention. At the same time, for those of ordinary skill in the art, according to the technical ideas of the present invention, there will be changes in the specific implementation methods and scope of application. Therefore, in summary, the content of this specification should not be understood as a limitation on the present invention.
Claims
1. A method for preparing an artificial valved blood vessel, characterized in that: The artificial valved blood vessel is composed of a tissue valve, an artificial blood vessel containing a valve sinus, and an artificial valve support ring; the tissue valve is located in the valve sinus of the artificial blood vessel containing the valve sinus, the artificial valve support ring is located outside the valve sinus of the artificial blood vessel containing the valve sinus, and the valve ring of the tissue valve overlaps with the artificial valve support ring; the tissue valve, the artificial blood vessel containing the valve sinus, and the artificial valve support ring are sutured and connected by medical sutures; The artificial blood vessel containing the valve sinus comprises a first conduit, a valve sinus and a second conduit, wherein the valve sinus is located between the distal end of the first conduit and the proximal end of the second conduit; the artificial blood vessel containing the valve sinus is a continuous and complete artificial blood vessel containing the valve sinus; The tissue valve is a complete three-leaflet structure valve cut from a processed bovine jugular vein, and the valve ring of the cut tissue valve is still annular; The method comprises the following steps: (1) The three-leaflet structure valve in the processed bovine jugular vein is cut off along the upper and lower edges of the valve ring at a certain distance from the blood vessel wall, and the valve ring of the cut tissue valve is still annular, and the valve leaflets and the valve ring still retain the complete valve structure and function; (2) placing the tissue valve in the valve sinus of the artificial blood vessel containing the valve sinus, and placing the artificial valve support ring outside the valve sinus of the artificial blood vessel containing the valve sinus, so that the artificial valve support ring and the valve ring of the tissue valve overlap; using medical sutures along the direction of the valve ring of the tissue valve, so that the medical sutures pass through the upper and lower edge blood vessel walls of the valve ring of the tissue valve, the valve sinus of the artificial blood vessel containing the valve sinus, and the suture holes on the artificial valve support ring, and sew the above three-layer structure together at the same time.
2. The method for preparing an artificial valved blood vessel according to claim 1, characterized in that: The inner diameters of the first tube and the second tube of the same artificial blood vessel containing a valve sinus are the same, and are the same as the inner diameter of the valve ring of the tissue valve located in the valve sinus; the inner diameter of the valve sinus of the same artificial blood vessel containing a valve sinus is larger than the inner diameters of the first tube and the second tube, and is the same as the outer diameter of the valve ring of the tissue valve located in the valve sinus; the valve sinus is generally convex relative to the first tube and the second tube.
3. The method for preparing an artificial valved blood vessel according to claim 1, characterized in that: The artificial blood vessel containing the valve sinus is made of medical polymer materials; the first pipe and the second pipe can be bent, cut and sutured, and can maintain a tubular shape and corresponding elasticity during operation and use.
4. The method for preparing an artificial valved blood vessel according to claim 1, characterized in that: The artificial valve support ring is an elastic sheet-like ring, and its shape is similar to the shape of the valve ring of a natural three-leaflet valve, which is a ring formed by three parabolas opening upward.
5. The method for preparing an artificial valved blood vessel according to claim 4, characterized in that: The inner diameter of the artificial valve support ring is the same as the outer diameter of the valve sinus of the artificial blood vessel containing the valve sinus.
6. The method for preparing an artificial valved blood vessel according to claim 4, characterized in that: The artificial valve supporting ring is made of medical polymer material or elastic metal material.
